Federated Hermes, Inc. Axsome Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$66.31 - $86.52 $464 - $605	-7 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$68.34 - $85.84 $1.42 Million - $1.78 Million	-20,724 Reduced 99.97%	7 $1,000
Q2 2020 Aug 13, 2020	SELL	$49.87 - $98.69 $713,490 - $1.41 Million	-14,307 Reduced 40.83%	20,731 $1.71 Million
Q1 2020 May 13, 2020	SELL	$41.2 - $101.31 $176,624 - $434,315	-4,287 Reduced 10.9%	35,038 $2.06 Million
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $437,802 - $2.78 Million	26,200 Added 199.62%	39,325 $4.07 Million
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $265,650 - $382,725	13,125 New	13,125 $266,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.